Difficulties in diagnosing the causes of stroke and myocardial infarction in young people: A clinical case study
https://doi.org/10.21518/ms2025-016
Abstract
Recently, the number of myocardial infarctions and strokes in young patients has been increasing. Most often these are non-atherogenic causes: congenital heart defects, coagulopathies, arteritis, etc. To discuss the difficulties of diagnosing the causes of strokes and myocardial infarctions in young patients, we present a clinical case of a 39-year-old patient with atrial septal defect and genetic thrombophilia, which resulted in myocardial infarction and embolic stroke. A special feature of this clinical case can be considered the fact of the development of embolic myocardial infarction during pregnancy in a patient with atrial septal defect surgery in childhood. However, the study on thrombophilia was not complete after a miscarriage during the first pregnancy. Suspicions of the formation of a right-left shunt were confirmed upon hospitalization due to embolic myocardial infarction. After cesarean delivery, endovascular occlusion of the atrial septal defect with an occluder was performed, and 4 years after the installation of the occluder, the patient developed an embolic stroke, as evidenced by the multiplicity of ischemic foci of the brain during imaging studies. Examination for thrombophilia after a repeated ischemic event revealed homozygous mutations in factor VII (A/A), FGB (A/A), heterozygous mutations in folate cycle genes (C/T polymorphism in the MTHFR gene, A/G polymorphism in the MTR gene), heterozygous polymorphism in the PAI-1 gene (4G/5G). The hematologist recommended constant anticoagulant therapy rivaroxaban at a dose of 2.5 mg 2 times a day. The described clinical case demonstrates the polyethology and complexity of the pathogenetic mechanisms of myocardial infarction and stroke in a young patient. If these events occur in young people, it is important to perform echocardiography (with a bubble test, if necessary), daily monitoring of electrocardiography, and laboratory examination for thrombophilia.
About the Authors
A. V. SolovievaRussian Federation
Aleхandra V. Solovieva, Dr. Sci. (Med.), Professor of the Faculty Therapy Department
9, Vysokovoltnaya St., Ryazan, 390026, Russia
N. N. Kiryukhina
Russian Federation
Nadezhda N. Kiryukhina, Cand. Sci. (Med.), Deputy Chief Physician for Medical and Diagnostic work, Head of the Regional Vascular Center
3a, Internationalnaya St., Ryazan, 390039, Russia
S. B. Aksentiev
Russian Federation
Sergei B. Aksentiev, Cand. Sci. (Med.), Associate Professor of the Faculty Therapy Department; Cardiologist
9, Vysokovoltnaya St., Ryazan, 390026, Russia
3a, Internationalnaya St., Ryazan, 390039, Russia
M. S. Yakushina
Russian Federation
Margarita S. Yakushina, Cand. Sci. (Med.), Associate Professor, Associate Professor of the Faculty Therapy Department; Head of the Department of Functional and Ultrasound Diagnostics
9, Vysokovoltnaya St., Ryazan, 390026, Russia
3a, Internationalnaya St., Ryazan, 390039, Russia
A. O. Antonenko
Russian Federation
Aleхandеr O. Antonenko, Head of the Department of X-ray Surgical Methods of Diagnosis and Treatment
85, Stroykov St., Ryazan, 390026, Russia
S. E. Lobkov
Russian Federation
Stepan E. Lobkov, Student of the Faculty of Medicine
9, Vysokovoltnaya St., Ryazan, 390026, Russia
References
1. Ivanov DO, Orel VI, Aleksandrovich YuS, Pshenisnov KV, Lomovceva RH. Diseases of the cardiovascular system as the leading cause of death in Russian Federation: ways of problem solution. Medicine and Health Care Organization. 2019;4(2):4–12. (In Russ.) Available at: https://ojs3.gpmu.org/index.php/medorg/article/view/579/581.
2. Selivestrova DV. Risk factors for development of myocardial infarction in women with preserved reproductive function. I.P. Pavlov Russian Medical Biological Herald. 2019;27(2):172–180. (In Russ.) https://doi.org/10.23888/PAVLOVJ2019272172-180.
3. Chumachenko NV, Kizhvatova NV, Kosmacheva HD, Pakholkov AN, Fedorchenko AN. Paradoxes in embolism: management of a young female patient with atrial septal defect after acute myocardial infarction. South Russian Journal of Therapeutic Practice. 2022;3(3):91–96. (In Russ.) https://doi.org/10.21886/2712-8156-2022-3-3-97-107.
4. Selivestrova DV, Evsina OV. Myocardial infarction of young patients: risk factors, course, clinic, management on the hospital treatment stage. Science of the Young (Eruditio Juvenium). 2013;(4):106–111. (In Russ.) Available at: https://naukamolod.rzgmu.ru/uploads/art/art86_501bf7.pdf
5. Kulesh AA, Mekhryakov SA, Syromyatnikova LI, Gorst NH, Drobakha SO, Nikolaeva EV. Paradoxial embolism as a cause of ischemic stroke in patient with sinus venosus atrial septal defect. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(5):123–129. (In Russ.) https://doi.org/10.14412/2074-2711-2021-5-123-129.
6. Bokeria LA, Kim AI, Zelenikin MM, Avramenko AA, Alekyan BG, Belov VA et al. Atrial septal defect. Clinical guidelines 2023. Russian Journal of Cardiology. 2023;28(8):55–88. (In Russ.) https://doi.org/10.15829/1560-4071-2023-5588.
7. Belopasova AV, Dobrynina LA, Kalashnikova LA, Chechetkin AO, Karshieva AR, Abugov SA et al. Pulmonary arteriovenous shunt – a rare cause of recurrent stroke due to paradoxical embolism. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2020;120(9):107–113. (In Russ.) https://doi.org/10.17116/jnevro2020120091107.
8. Mravyan SR, Kovalenko TS, Shuginin IO, Budykina TS, Fedorova SI. Clinical cases of myocardial infarction in pregnant women: the role of hereditary thrombophilia. Almanac of Clinical Medicine. 2020;48(5):341–347. (In Russ.) https://doi.org/10.18786/2072-0505-2020-48-059.
9. Abid L, Frikha F, Bahloul Z, Kammoun S. Acute myocardial infarction in young adults with Antiphospholipid syndrome: report of two cases and literature review. Pan Afr Med J. 2011;8:13. https://doi.org/10.4314/pamj.v8i1.71062.
10. Osula S, Bell GM, Hornung RS. Acute myocardial infarction in young adults: causes and management. Postgrad Med J. 2002;78(915):27–30. https://doi.org/10.1136/pmj.78.915.27.
11. Акжигитов РГ, Алекян БГ, Алферова ВВ, Белкин АА, Беляева ИА, Бойцов СА и др. Ишемический инсульт и транзиторная ишемическая атака у взрослых – 2021–2022–2023: клинические рекомендации. М.; 2021. 168 с. Режим доступа: http://disuria.ru/_ld/11/1106_kr21G45G46I63MZ.pdf.
12. Stepien K, Nowak K, Wypasek E, Zalewski J, Undas A. High prevalence of inherited thrombophilia and antiphospholipid syndrome in myocardial infarction with non-obstructive coronary arteries: Comparison with cryptogenic stroke. Int J Cardiol. 2019;290:1–6. https://doi.org/10.1016/j.ijcard.2019.05.037.
13. Alameh A, Jabri A, Aleyadeh W, Nasser F, Al Abdouh A, Kondapaneni M et al. Pregnancy-Associated Myocardial Infarction: A Review of Current Practices and Guidelines. Curr Cardiol Rep. 2021;23(10):142. https://doi.org/10.1007/s11886-021-01579-z.
14. Gédéon T, Akl E, D’Souza R, Altit G, Rowe H, Flannery A et al. Acute Myocardial Infarction in Pregnancy. Curr Probl Cardiol. 2022;47(11):1013–1027. https://doi.org/10.1016/j.cpcardiol.2022.101327.
15. Murashko AV, Drapkina YuS, Koroleva NS. The course of pregnancy and blood coagulation system. V.F. Snegirev Archives of Obstetrics and Gynecology. 2016;3(4):181–187. (In Russ.) https://doi.org/10.18821/2313-8726-2016-3-4-181-187.
16. Makatsariya AD, Bitzadze VO. Antifosfolipidnyy sindrom, geneticheskiye trombofilii v patogeneze osnovnyh form akusherskoy patologii. RMJ. 2006;(2-10). (In Russ.) Available at: https://www.rmj.ru/articles/ginekologiya/Antifosfolipidnyy_sindrom_geneticheskie_trombofilii_v_patogeneze_osnovnyh_form_akusherskoy_patologii/.
17. Grygiel-Górniak B, Mazurkiewicz Ł. Positive antiphospholipid antibodies: observation or treatment? J Thromb Thrombolysis. 2023;56(2):301–314. https://doi.org/10.1007/s11239-023-02834-6.
18. Yang R, Zhang J, Zhang L, Liu Y, Guo Q. Combined detection of anticardiolipin and anti-β2-glycoprotein 1 antibodies may predict pregnancy outcome. Am J Transl Res. 2022;14(3):1750–1756. Available at: https://pubmed.ncbi.nlm.nih.gov/35422959.
19. Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC et al. ACR/EULAR APS Classification Criteria Collaborators. 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2023;82(10):1258–1270. https://doi.org/10.1136/ard-2023-224609.
20. Belgrave K, Cardozo S. Thrombus formation on amplatzer septal occlude device: pinning down the cause. Case Rep Cardiol. 2014:2014:457850. https://doi.org/10.1155/2014/457850.
21. Fernando RR, Koranne KP, Barker CM. AMPLATZER Septal Occluder failure resulting in paradoxical cerebral embolism. Tex Heart Inst J. 2012;39(5):647–652. Available at: https://pubmed.ncbi.nlm.nih.gov/23109759.
22. Belopasova AV, Dobrinina LA, Chechetkin AO, Karshieva AR, Ananieva LYu, Pushkina DS. Atrial septal defects: the role in the development of cerebral circulation disorders caused by paradoxical embolism. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(6):142–146. (In Russ.) https://doi.org/10.14412/2074-2711-2021-6-142-146.
23. Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(14):698–800. https://doi.org/10.1161/CIR.0000000000000603.
Review
For citations:
Solovieva AV, Kiryukhina NN, Aksentiev SB, Yakushina MS, Antonenko AO, Lobkov SE. Difficulties in diagnosing the causes of stroke and myocardial infarction in young people: A clinical case study. Meditsinskiy sovet = Medical Council. 2025;(6):301-308. (In Russ.) https://doi.org/10.21518/ms2025-016